Plitidepsin found to work better than remdesivir for treating COVID-19 Credit: CC0 Public Domain A large team of researchers affiliated with a host of institutions in the U.S., France and Spain has found that the drug plitidepsin worked better at treating COVID-19 than did remdesivir in a lab setting. In their paper published in the […]
Read More
Hem/Onc Roundup: Radiation for Prostate Cancer, Multiple Myeloma Clinical Trials, and More DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, about promising results from current clinical trials for newly-diagnosed multiple myeloma. Recent Clinical Trials for Newly Diagnosed Multiple Myeloma, with Dr. Raj Chakraborty […]
Read More
Friday Frontline: Oncologist With Terminal Cancer Gifted Tickets to 2021 Super Bowl, Indiana … A trip to the 2021 Super Bowl allows an oncologist with terminal cancer to fulfill a lifelong dream Dr. Brian Lane, a urological oncologist at Spectrum Health in Grand Rapids, Michigan, was first diagnosed with cancer in 2018. Treatment initially went […]
Read More
Leading Cancer Organizations Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You ATLANTA and PLYMOUTH MEETING, Pa., Jan. 28, 2021 /PRNewswire/ — The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the […]
Read More
Cancer Trait Revealed to Be a Tragic Flaw Cancer Trait Revealed to Be a Tragic Flaw genprowebdirectory Scroll Up MORE CONTENT We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.Got it! Published at […]
Read More
Decline in Cancer Death Rate Largely Driven by Decreasing Lung Cancer Mortality In 2021, cancer-related death in the United States is projected to continue to decrease, a clinical reality largely driven by declining non-small cell lung cancer (NSCLC) mortality, according to the results of a study published in CA Cancer Journal for Clinicians.1 The American […]
Read More RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo … TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced a manufacturing agreement with Cosmo Pharmaceuticals NV (SIX: COPN) (“Cosmo”) to further expand manufacturing capacity for opaganib (Yeliva®, […]
Read More
Liposomal Doxorubicin Market Segmented by Product, Top Manufacturers, Geography Trends … Market Study Report, LLC adds latest research report on ‘ Liposomal Doxorubicin Market’, which delivers a comprehensive study on current industry trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key […]
Read More Cancer patients needing surgery to increase by 5 million globally by 2040: Lancet study The research estimates that there will be a shortfall of about 1,99,000 surgeons and 87,000 anaesthetists to meet the demand in 2040. A modelling and in-depth analysis of the growing demand for cancer surgery, based on data from 183 countries in recent years, predicts […]
Read More
Researchers find drug that is 27.5 times more potent than remdesivir against Covid-19 Researchers in the United States and France have found a drug that has more potential to treat coronavirus than remdesivir. According to a peer-reviewed study published in the Science journal, a drug called plitidepsin is 27.5 times more potent than remdesivir. The […]
Read More